David Whitlock

Inventor & Co-Founder at AOBiome Therapeutics

David Whitlock is the Inventor and co-founder of AOBiome. His initial discovery that Ammonia Oxidizing Bacteria could be reintroduced to the human microbiome formed the scientific basis for AOBiome’s efforts. Mr. Whitlock holds both an MS and a BS in Chemical Engineering from MIT and is the author or co-author of several key patents in the field.

Location

Cambridge, United States

Links


Org chart

No direct reports

Teams


Offices


AOBiome Therapeutics

AOBiome is focused on transforming human health by developing microbiome-based therapies for inflammatory conditions.


Industries

Employees

11-50

Links